The US FDA Grants 510(k) clearance to Stryker’s OptaBlate BVN System for Vertebrogenic Pain

Shots:The US FDA has granted 510(k) clearance to the OptaBlate BVN system for minimally invasive procedure designed to deliver long-lasting relief from vertebrogenic painOptaBlate BVN achieves ≥1cm lesions in 7min. & features a steerable curved introducer, with microinfusion tech to minimize impedance & charring, plus 10-gauge access tools for precisionOptaBlate BVN combines…

ByRidhi RastogiMay 20, 2025

News

Stryker to Acquire Inari Medical for ~$4.9B

Shots:Stryker has signed a definitive agreement to initiate a tender offer for acquiring all the issued & outstanding shares of Inari Medical for $80 per share in cash, making it a total value of ~$4.9B Upon completion, Stryker will acquire remaining shares in a second-step merger at the same price. The deal is…

BySenior EditorJanuary 7, 2025

INSIGHTS+

PharmaShots’ Key Highlights of Third Quarter 2024

Shots:The third quarter of 2024 highlights major acquisitions in the pharma and biotech industry along with clinical trial results and approvals. The highlight of the quarter was Eli Lilly's acquisition of Morphic Holdings for ~$3.2BThis quarter also showcased multiple clinical trial results including Roche's P-I Study Data of CT-996 to treat ObesityOur…

BySaurabh ChaubeyOctober 1, 2024

INSIGHTS+

PharmaShots’ Key Highlights of Second Quarter 2024

Shots:The second quarter of 2024 highlights major acquisitions in the pharma and biotech industry along with clinical trial results and approvals. The highlight of the quarter was Vertex’ acquisition of Alpine Immune Sciences for ~$4.9BThis quarter also showcased multiple clinical trial results including Moderna’s P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19…

BySenior EditorJuly 2, 2024

INSIGHTS+

PharmaShots’ Key Highlights of First Quarter 2022

The first quarter of 2022 highlights the approvals, clinical data & acquisitions. There are major alliances in this quarter which include Biocon acquired Viatris’ biosimilars assets for ~$3.335B, Stryker signed a definitive agreement to acquire Vocera Communications for ~$3.09B, Biohaven acquire Channel Biosciences for ~$3BThe first quarter of the year also showcases regulatory events…

BySenior EditorMarch 31, 2022

TOP 20

Top 20 Medical Device Companies Based on 2018 Revenue

The Medical device market is growing with greater needs of patients and with their emerging diseases. 2018 has shown major advancement in medical device needs and upgrades with 55 novel drug approvals. The year 2018 has shown a slight change in the ledger of top 20 firms while Medtronic holds its first position with a…

ByPrince GiriJune 6, 2019

The US FDA Grants 510(k) clearance to Stryker’s OptaBlate BVN System for Vertebrogenic Pain

Stryker to Acquire Inari Medical for ~$4.9B

PharmaShots’ Key Highlights of Third Quarter 2024

PharmaShots’ Key Highlights of Second Quarter 2024

PharmaShots’ Key Highlights of First Quarter 2022

Top 20 Medical Device Companies Based on 2018 Revenue

Contact US

OUR INFORMATION

FOLLW US

The US FDA Grants 510(k) clearance to Stryker’s OptaBlate BVN System for Vertebrogenic Pain

Stryker to Acquire Inari Medical for ~$4.9B

PharmaShots’ Key Highlights of Third Quarter 2024

PharmaShots’ Key Highlights of Second Quarter 2024

PharmaShots’ Key Highlights of First Quarter 2022

Top 20 Medical Device Companies Based on 2018 Revenue

FOLLW US

Sign Up to Our Newsletter